1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Idiopathic Gastroparesis Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Idiopathic Gastroparesis Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Prokinetic Agents 1.4.3 Antiemetic Agents 1.4.4 Others 1.5 Market by Application 1.5.1 Global Idiopathic Gastroparesis Drugs Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Private Clinics 1.5.4 Drug Stores 1.5.5 E-Commerce 1.6 Coronavirus Disease 2019 (Covid-19): Idiopathic Gastroparesis Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Idiopathic Gastroparesis Drugs Industry 1.6.1.1 Idiopathic Gastroparesis Drugs Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Idiopathic Gastroparesis Drugs Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Idiopathic Gastroparesis Drugs Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Idiopathic Gastroparesis Drugs Market Perspective (2015-2026) 2.2 Idiopathic Gastroparesis Drugs Growth Trends by Regions 2.2.1 Idiopathic Gastroparesis Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Idiopathic Gastroparesis Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Idiopathic Gastroparesis Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Idiopathic Gastroparesis Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Idiopathic Gastroparesis Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Idiopathic Gastroparesis Drugs Players by Market Size 3.1.1 Global Top Idiopathic Gastroparesis Drugs Players by Revenue (2015-2020) 3.1.2 Global Idiopathic Gastroparesis Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Idiopathic Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Idiopathic Gastroparesis Drugs Market Concentration Ratio 3.2.1 Global Idiopathic Gastroparesis Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Idiopathic Gastroparesis Drugs Revenue in 2019 3.3 Idiopathic Gastroparesis Drugs Key Players Head office and Area Served 3.4 Key Players Idiopathic Gastroparesis Drugs Product Solution and Service 3.5 Date of Enter into Idiopathic Gastroparesis Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Idiopathic Gastroparesis Drugs Historic Market Size by Type (2015-2020) 4.2 Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Type (2021-2026) 5 Idiopathic Gastroparesis Drugs Breakdown Data by Application (2015-2026) 5.1 Global Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 5.2 Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Idiopathic Gastroparesis Drugs Market Size (2015-2020) 6.2 Idiopathic Gastroparesis Drugs Key Players in North America (2019-2020) 6.3 North America Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) 6.4 North America Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Idiopathic Gastroparesis Drugs Market Size (2015-2020) 7.2 Idiopathic Gastroparesis Drugs Key Players in Europe (2019-2020) 7.3 Europe Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) 7.4 Europe Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 8 China 8.1 China Idiopathic Gastroparesis Drugs Market Size (2015-2020) 8.2 Idiopathic Gastroparesis Drugs Key Players in China (2019-2020) 8.3 China Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) 8.4 China Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Idiopathic Gastroparesis Drugs Market Size (2015-2020) 9.2 Idiopathic Gastroparesis Drugs Key Players in Japan (2019-2020) 9.3 Japan Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) 9.4 Japan Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Idiopathic Gastroparesis Drugs Market Size (2015-2020) 10.2 Idiopathic Gastroparesis Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 11 India 11.1 India Idiopathic Gastroparesis Drugs Market Size (2015-2020) 11.2 Idiopathic Gastroparesis Drugs Key Players in India (2019-2020) 11.3 India Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) 11.4 India Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Idiopathic Gastroparesis Drugs Market Size (2015-2020) 12.2 Idiopathic Gastroparesis Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) 12.4 Central & South America Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Sumitomo 13.1.1 Sumitomo Company Details 13.1.2 Sumitomo Business Overview and Its Total Revenue 13.1.3 Sumitomo Idiopathic Gastroparesis Drugs Introduction 13.1.4 Sumitomo Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020)) 13.1.5 Sumitomo Recent Development 13.2 Cadila Pharmaceuticals 13.2.1 Cadila Pharmaceuticals Company Details 13.2.2 Cadila Pharmaceuticals Business Overview and Its Total Revenue 13.2.3 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Introduction 13.2.4 Cadila Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.2.5 Cadila Pharmaceuticals Recent Development 13.3 Sanofi 13.3.1 Sanofi Company Details 13.3.2 Sanofi Business Overview and Its Total Revenue 13.3.3 Sanofi Idiopathic Gastroparesis Drugs Introduction 13.3.4 Sanofi Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.3.5 Sanofi Recent Development 13.4 Teva 13.4.1 Teva Company Details 13.4.2 Teva Business Overview and Its Total Revenue 13.4.3 Teva Idiopathic Gastroparesis Drugs Introduction 13.4.4 Teva Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.4.5 Teva Recent Development 13.5 Johnson & Johnson 13.5.1 Johnson & Johnson Company Details 13.5.2 Johnson & Johnson Business Overview and Its Total Revenue 13.5.3 Johnson & Johnson Idiopathic Gastroparesis Drugs Introduction 13.5.4 Johnson & Johnson Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.5.5 Johnson & Johnson Recent Development 13.6 Pfizer 13.6.1 Pfizer Company Details 13.6.2 Pfizer Business Overview and Its Total Revenue 13.6.3 Pfizer Idiopathic Gastroparesis Drugs Introduction 13.6.4 Pfizer Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.6.5 Pfizer Recent Development 13.7 Kyowa Kirin Pharmaceuticals 13.7.1 Kyowa Kirin Pharmaceuticals Company Details 13.7.2 Kyowa Kirin Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Introduction 13.7.4 Kyowa Kirin Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.7.5 Kyowa Kirin Pharmaceuticals Recent Development 13.8 Hanmi Pharm 13.8.1 Hanmi Pharm Company Details 13.8.2 Hanmi Pharm Business Overview and Its Total Revenue 13.8.3 Hanmi Pharm Idiopathic Gastroparesis Drugs Introduction 13.8.4 Hanmi Pharm Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.8.5 Hanmi Pharm Recent Development 13.9 Ani Pharmaceuticals 13.9.1 Ani Pharmaceuticals Company Details 13.9.2 Ani Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Introduction 13.9.4 Ani Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) 13.9.5 Ani Pharmaceuticals Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Idiopathic Gastroparesis Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Idiopathic Gastroparesis Drugs Revenue Table 3. Ranking of Global Top Idiopathic Gastroparesis Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Idiopathic Gastroparesis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Prokinetic Agents Table 6. Key Players of Antiemetic Agents Table 7. Key Players of Others Table 8. COVID-19 Impact Global Market: (Four Idiopathic Gastroparesis Drugs Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Idiopathic Gastroparesis Drugs Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Idiopathic Gastroparesis Drugs Players to Combat Covid-19 Impact Table 13. Global Idiopathic Gastroparesis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Idiopathic Gastroparesis Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Idiopathic Gastroparesis Drugs Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Idiopathic Gastroparesis Drugs Market Share by Regions (2015-2020) Table 17. Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Idiopathic Gastroparesis Drugs Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Idiopathic Gastroparesis Drugs Market Growth Strategy Table 23. Main Points Interviewed from Key Idiopathic Gastroparesis Drugs Players Table 24. Global Idiopathic Gastroparesis Drugs Revenue by Players (2015-2020) (Million US$) Table 25. Global Idiopathic Gastroparesis Drugs Market Share by Players (2015-2020) Table 26. Global Top Idiopathic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Idiopathic Gastroparesis Drugs as of 2019) Table 27. Global Idiopathic Gastroparesis Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Idiopathic Gastroparesis Drugs Product Solution and Service Table 30. Date of Enter into Idiopathic Gastroparesis Drugs Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 33. Global Idiopathic Gastroparesis Drugs Market Size Share by Type (2015-2020) Table 34. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Type (2021-2026) Table 35. Global Idiopathic Gastroparesis Drugs Market Size Share by Application (2015-2020) Table 36. Global Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 37. Global Idiopathic Gastroparesis Drugs Market Size Share by Application (2021-2026) Table 38. North America Key Players Idiopathic Gastroparesis Drugs Revenue (2019-2020) (Million US$) Table 39. North America Key Players Idiopathic Gastroparesis Drugs Market Share (2019-2020) Table 40. North America Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 41. North America Idiopathic Gastroparesis Drugs Market Share by Type (2015-2020) Table 42. North America Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 43. North America Idiopathic Gastroparesis Drugs Market Share by Application (2015-2020) Table 44. Europe Key Players Idiopathic Gastroparesis Drugs Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Idiopathic Gastroparesis Drugs Market Share (2019-2020) Table 46. Europe Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 47. Europe Idiopathic Gastroparesis Drugs Market Share by Type (2015-2020) Table 48. Europe Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 49. Europe Idiopathic Gastroparesis Drugs Market Share by Application (2015-2020) Table 50. China Key Players Idiopathic Gastroparesis Drugs Revenue (2019-2020) (Million US$) Table 51. China Key Players Idiopathic Gastroparesis Drugs Market Share (2019-2020) Table 52. China Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 53. China Idiopathic Gastroparesis Drugs Market Share by Type (2015-2020) Table 54. China Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 55. China Idiopathic Gastroparesis Drugs Market Share by Application (2015-2020) Table 56. Japan Key Players Idiopathic Gastroparesis Drugs Revenue (2019-2020) (Million US$) Table 57. Japan Key Players Idiopathic Gastroparesis Drugs Market Share (2019-2020) Table 58. Japan Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 59. Japan Idiopathic Gastroparesis Drugs Market Share by Type (2015-2020) Table 60. Japan Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 61. Japan Idiopathic Gastroparesis Drugs Market Share by Application (2015-2020) Table 62. Southeast Asia Key Players Idiopathic Gastroparesis Drugs Revenue (2019-2020) (Million US$) Table 63. Southeast Asia Key Players Idiopathic Gastroparesis Drugs Market Share (2019-2020) Table 64. Southeast Asia Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 65. Southeast Asia Idiopathic Gastroparesis Drugs Market Share by Type (2015-2020) Table 66. Southeast Asia Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 67. Southeast Asia Idiopathic Gastroparesis Drugs Market Share by Application (2015-2020) Table 68. India Key Players Idiopathic Gastroparesis Drugs Revenue (2019-2020) (Million US$) Table 69. India Key Players Idiopathic Gastroparesis Drugs Market Share (2019-2020) Table 70. India Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 71. India Idiopathic Gastroparesis Drugs Market Share by Type (2015-2020) Table 72. India Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 73. India Idiopathic Gastroparesis Drugs Market Share by Application (2015-2020) Table 74. Central & South America Key Players Idiopathic Gastroparesis Drugs Revenue (2019-2020) (Million US$) Table 75. Central & South America Key Players Idiopathic Gastroparesis Drugs Market Share (2019-2020) Table 76. Central & South America Idiopathic Gastroparesis Drugs Market Size by Type (2015-2020) (Million US$) Table 77. Central & South America Idiopathic Gastroparesis Drugs Market Share by Type (2015-2020) Table 78. Central & South America Idiopathic Gastroparesis Drugs Market Size by Application (2015-2020) (Million US$) Table 79. Central & South America Idiopathic Gastroparesis Drugs Market Share by Application (2015-2020) Table 80. Sumitomo Company Details Table 81. Sumitomo Business Overview Table 82. Sumitomo Product Table 83. Sumitomo Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 84. Sumitomo Recent Development Table 85. Cadila Pharmaceuticals Company Details Table 86. Cadila Pharmaceuticals Business Overview Table 87. Cadila Pharmaceuticals Product Table 88. Cadila Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 89. Cadila Pharmaceuticals Recent Development Table 90. Sanofi Company Details Table 91. Sanofi Business Overview Table 92. Sanofi Product Table 93. Sanofi Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 94. Sanofi Recent Development Table 95. Teva Company Details Table 96. Teva Business Overview Table 97. Teva Product Table 98. Teva Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 99. Teva Recent Development Table 100. Johnson & Johnson Company Details Table 101. Johnson & Johnson Business Overview Table 102. Johnson & Johnson Product Table 103. Johnson & Johnson Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 104. Johnson & Johnson Recent Development Table 105. Pfizer Company Details Table 106. Pfizer Business Overview Table 107. Pfizer Product Table 108. Pfizer Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 109. Pfizer Recent Development Table 110. Kyowa Kirin Pharmaceuticals Company Details Table 111. Kyowa Kirin Pharmaceuticals Business Overview Table 112. Kyowa Kirin Pharmaceuticals Product Table 113. Kyowa Kirin Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 114. Kyowa Kirin Pharmaceuticals Recent Development Table 115. Hanmi Pharm Business Overview Table 116. Hanmi Pharm Product Table 117. Hanmi Pharm Company Details Table 118. Hanmi Pharm Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 119. Hanmi Pharm Recent Development Table 120. Ani Pharmaceuticals Company Details Table 121. Ani Pharmaceuticals Business Overview Table 122. Ani Pharmaceuticals Product Table 123. Ani Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2015-2020) (Million US$) Table 124. Ani Pharmaceuticals Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Idiopathic Gastroparesis Drugs Market Share by Type: 2020 VS 2026 Figure 2. Prokinetic Agents Features Figure 3. Antiemetic Agents Features Figure 4. Others Features Figure 5. Global Idiopathic Gastroparesis Drugs Market Share by Application: 2020 VS 2026 Figure 6. Hospital Pharmacies Case Studies Figure 7. Private Clinics Case Studies Figure 8. Drug Stores Case Studies Figure 9. E-Commerce Case Studies Figure 10. Idiopathic Gastroparesis Drugs Report Years Considered Figure 11. Global Idiopathic Gastroparesis Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Idiopathic Gastroparesis Drugs Market Share by Regions: 2020 VS 2026 Figure 13. Global Idiopathic Gastroparesis Drugs Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Idiopathic Gastroparesis Drugs Market Share by Players in 2019 Figure 16. Global Top Idiopathic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Idiopathic Gastroparesis Drugs as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Idiopathic Gastroparesis Drugs Revenue in 2019 Figure 18. North America Idiopathic Gastroparesis Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Idiopathic Gastroparesis Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Idiopathic Gastroparesis Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Idiopathic Gastroparesis Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Idiopathic Gastroparesis Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Idiopathic Gastroparesis Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Sumitomo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Sumitomo Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 27. Cadila Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Cadila Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 29. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Sanofi Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 31. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Teva Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 33. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Johnson & Johnson Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 35. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Pfizer Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 37. Kyowa Kirin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Kyowa Kirin Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 39. Hanmi Pharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Hanmi Pharm Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 41. Ani Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Ani Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2015-2020) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

Sumitomo Cadila Pharmaceuticals Sanofi Teva Johnson & Johnson Pfizer Kyowa Kirin Pharmaceuticals Hanmi Pharm Ani Pharmaceuticals